Prospective Associations of Obesity and Obesity Severity With 9 Cardiovascular Outcomes: The Cross-Cohort Collaboration
Abstract
BACKGROUND: Obesity is an established risk factor for cardiovascular disease (CVD); however, the overall and sex-specific relationships across the full spectrum of body mass index (BMI), particularly severe obesity defined as class 2 (BMI 35 to <40.0 kg/m 2 ) and class 3 (BMI ≥40 kg/m 2 ), and long-term CVD outcomes remain incompletely described. METHODS: We included 289 875 participants (mean age, 60.3 years; 79.2% women) from 21 cohorts of the Cross-Cohort Collaboration enrolled between 1948 and 2015 with harmonized BMI data, a BMI ≥18.5 kg/m 2 , and at least one of nine adjudicated outcomes: time to first fatal and non-fatal myocardial infarction (MI), fatal and nonfatal stroke, heart failure (HF), atrial fibrillation (AF), total coronary heart disease (CHD), total CVD, CHD mortality, CVD mortality, and all-cause mortality. Multivariable Cox proportional hazard models with restricted cubic splines were used to estimate the hazard ratio (HR) of BMI for each outcome, adjusting for demographic and clinical risk factors. RESULTS: Over 19.2 median years (25th, 11.6; 75th, 23.5 percentile) of follow-up, there were a total of 15 542 incident MI events, 15 467 incident stroke events, 14 172 incident HF events, 9066 diagnosed AF, and 113 918 total deaths, of which 14 647 were CHD-related and 28 879 were CVD-related. Overall, compared with individuals with normal weight, those with class 2 and class 3 obesity had the highest risk of HF (HR, 2.1, 95% CI, 2.0–2.3, and HR, 3.0, 95% CI, 2.7–3.2, respectively) and AF (HR, 1.8, 95% CI 1.7–2.0, and HR, 2.8, 95% CI, 2.5–3.1, respectively). Compared with men, women experienced higher relative increases in the risk associated with severe obesity for outcomes stroke, CVD, and all-cause mortality (P for interaction: <0.001, 0.003, and <0.001, respectively). Furthermore, in men, no increase in stroke risk was observed with higher BMI categories (P trend=0.49), whereas in women, the risk of stroke plateaued across obesity subclasses (compared with normal weight) yet remained significantly increased. CONCLUSIONS: Higher BMI was robustly associated with increased risk for most outcomes, particularly HF and AF, even after adjusting for traditional risk factors. Observed sex differences in the relative hazard of higher BMI categories and stroke, total CVD, and all-cause mortality suggest potential differences in underlying biological mechanisms.
Article Details
Authors (34)
Zeina A. Dardari
Johns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, Baltimore, MD (Z.A.D., Z.Y., Y.J., S.B., K.M., M.J.B.).
Zhiqi Yao
Jianjun Zhang
Giorgos Bakoyannis
Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University Indianapolis, IN (Z.A.D., J.Z., G.B., H.N., L.K.S.).
Hongmei Nan
Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University Indianapolis, IN (Z.A.D., J.Z., G.B., H.N., L.K.S.).
Lisa K. Staten
Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University Indianapolis, IN (Z.A.D., J.Z., G.B., H.N., L.K.S.).
Kunal K. Jha
Division of Chemistry and Chemical Engineering
Erfan Tasdighi
Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ (E.T.).
Yara Jelwan
Johns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, Baltimore, MD (Z.A.D., Z.Y., Y.J., S.B., K.M., M.J.B.).
Semenawit Burka
Johns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, Baltimore, MD (Z.A.D., Z.Y., Y.J., S.B., K.M., M.J.B.).
Kunihiro Matsushita
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (K.M.).
Eleanor M. Simonsick
Joao A.C. Lima
Department of Medicine, Division of Cardiology, Johns Hopkins School of Medicine, Baltimore, MD (J.A.C.L., W.S.P.).
Bruce M. Psaty
Debbie L. Cohen
Division of Renal-Electrolyte and Hypertension, Department of Medicine, University of Pennsylvania, Philadelphia
Lawrence J. Appel
Amit Khera
Amil M. Shah
Michael E. Hall
Department of Medicine, University of Mississippi Medical Center, Jackson, MS (M.E.H.).
Suzanne E. Judd
Shelley A. Cole
Population Health Program, Texas Biomedical Research Institute, San Antonio, TX (S.A.C.).
Ramachandran S. Vasan
Framingham Heart Study, National Heart, Lung, and Blood Institute, National Institutes of Health and Boston University, Framingham, MA, USA.
Emelia J. Benjamin
Peggy M. Cawthon
Eric Orwoll
Division of Endocrinology, Diabetes and Clinical Nutrition, School of Medicine, Oregon Health & Science University, Portland, OR (E.O.).
Michael J. LaMonte
Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY (M.J.L.).
Charles B. Eaton
Samar R. El Khoudary
University of Pittsburgh School of Public Health, Department of Epidemiology, Pittsburgh, PA (S.R.E.).
Rebecca C. Thurston
Departments of Psychiatry, University of Pittsburgh School of Medicine, PA (R.C.T.).
Carol A. Derby
Departments of Neurology and Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY (C.A.D.).
Paulo A. Lotufo
Isabela M. Bensenor
Márcio Sommer Bittencourt
Center for Clinical and Epidemiologic Research, Hospital Universitario, University of Sao Paulo, Sao Paulo, Brazil (P.A.L., I.M.B., M.S.B.)
Michael J. Blaha